All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
strong>Heron Therapeutics Inc., of Redwood City, Calif., has initiated a phase II trial of HTX-011, the company's lead candidate for the prevention of postoperative pain.